Aditxt, Inc. - 8-K Filing
Aditxt filed an 8-K on May 31, 2026, announcing the resignation of CEO Amro Albanna and COO Rowena Albanna effective June 5, along with Dr. Shahrokh Shabahang's departure from the board but continued role as Chief Innovation Officer. The company appointed Jeffrey M. Busch as interim CEO; he previously led a NYSE-listed healthcare REIT valued over $1 billion and will receive an annual base salary of $500,000 under his new arrangement. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $ADTX